Analyst stock forecast
AgomAb Therapeutics NV - ADRs representing one common share. Forecast: $33.00 Analyst Target
AGMB has a $33.00 target, Strong Buy rating and 5 analysts. As of 2026-08-16.
Direct answer
AgomAb Therapeutics NV - ADRs representing one common share.'s average price target is $33.00.
The target implies +149.6% from the recorded current price, and the consensus rating is Strong Buy.
The low target implies +111.8%, the high target implies +172.3%, and the range spans 60.5% of the current price.
Forecast evidence checked August 16, 2026.
Get free AgomAb Therapeutics NV - ADRs representing one common share. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $13.22
- Average price target
- $33.00
- High price target
- $36.00
- Low price target
- $28.00
- Low target gap
- +111.8%
- Target upside
- +149.6%
- High target gap
- +172.3%
- Target range width
- 60.5%
- Consensus rating
- Strong Buy
- Analysts
- 5
- Evidence date
- August 16, 2026
- Valid through
- August 23, 2026
Explore related company data
View AgomAb Therapeutics NV - ADRs representing one common share.'s price target rangeView AgomAb Therapeutics NV - ADRs representing one common share.'s target upside or downsideView AgomAb Therapeutics NV - ADRs representing one common share.'s analyst consensus ratingReturn to AgomAb Therapeutics NV - ADRs representing one common share. profile
Read the frequently asked questions.
What is AgomAb Therapeutics NV - ADRs representing one common share.'s average price target?
AgomAb Therapeutics NV - ADRs representing one common share.'s verified average price target is $33.00. The target range is $28.00 to $36.00.
How far are AgomAb Therapeutics NV - ADRs representing one common share.'s low and high targets from the recorded price?
The low target implies +111.8%, while the high target implies +172.3%.
How many analysts are included in AgomAb Therapeutics NV - ADRs representing one common share.'s consensus?
The verified consensus includes 5 analysts.
How is AgomAb Therapeutics NV - ADRs representing one common share.'s target upside or downside calculated?
The average target of $33.00 is divided by the recorded price of $13.22, then one is subtracted to produce +149.6%. This does not guarantee a future return.
When was AgomAb Therapeutics NV - ADRs representing one common share.'s analyst forecast verified?
The data was verified on 2026-08-16. The dataset is valid through 2026-08-23.